BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Ubiquitin-like modifier activating enzyme 2 (UBA2; SAE2)

August 18, 2016 7:00 AM UTC

Patient sample and cell culture studies suggest inhibiting UBA2 could help treat colorectal cancer. In tissue samples from stage II and III colorectal cancer patients, tumor levels of UBA2 were higher...